Short Interest in Orion Oyj (OTCMKTS:ORINF) Drops By 27.3%

Orion Oyj (OTCMKTS:ORINF) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 328,400 shares, a decrease of 27.3% from the January 15th total of 451,800 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is presently 1,642.0 days.

Orion Oyj Price Performance

ORINF stock remained flat at $48.65 during trading on Friday. Orion Oyj has a 12-month low of $48.65 and a 12-month high of $48.65. The company’s 50 day moving average price is $48.65 and its 200 day moving average price is $47.75.

About Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.